Examples



mdbootstrap.com



 
Статья
2022

Synthesis and antimicrobial activity of N-(indol-5-yl)trifluoroacetamides and indol-5-ylaminium trifluoroacetates substituted in the pyrrole ring


S. A. YamashkinS. A. Yamashkin, I. S. StepanenkoI. S. Stepanenko
Российский химический вестник
https://doi.org/10.1007/s11172-022-3506-2
Abstract / Full Text

Based on a series of 1H-indol-5-ylamines substituted in the pyrrole ring, the corresponding N-(indol-5-yl)trifluoroacetamides and indol-5-ylaminium trifluoroacetates were prepared. An in silico study showed a wide range of their biological activity, including antimicrobial, antiviral, antiprotozoal, anthelmintic, and antifungal effects. The results of in silico and in vitro screening for antimicrobial activity correlate with each other. All compounds are capable of inhibiting the growth of the tested microorganism strains. The dependence of minimum inhibitory concentrations on the nature of the substituents at the benzene and pyrrole rings of the indole system was revealed.

Author information
  • Evseviev Mordovian State Pedagogical University, 11a ul. Studencheskaya, 430007, Saranks, Russian FederationS. A. Yamashkin
  • National Research Mordovia State University, 68 ul. Bolshevitskaya, 430005, Saransk, Russian FederationI. S. Stepanenko
References
  1. G. A. Chesnokov, A. A. Ageshina, A. V. Maryanova, S. A. Rzhevskiy, P. S. Gribanov, M. A. Topchiy, M. S. Nechaev, A. F. Asachenko, Russ. Chem. Bull., 2020, 69, 2370; DOI: https://doi.org/10.1007/s11172-020-3028-8.
  2. M. S. Kobzev, A. A. Titov, A. V. Varlamov, Russ. Chem. Bull., 2021, 70, 1213; DOI: https://doi.org/10.1007/s11172-021-3208-1.
  3. Certificate of authorship 548608 USSR; Byul. Izobret. [Inventor Bull.], 1977, No. 8 (in Russian).
  4. I. S. Stepanenko, S. A. Yamashkin, Yu. A. Kostina, A. A. Batarsheva, E. D. Slastnikov, Problemy Med. Micologii [Problems of Med. Mycology], 2018, 20, 117 (in Russian).
  5. Pat. RU 2675806; Byul. Izobret. [Inventor Bull.], 2018, No. 36 (in Russian).
  6. I. S. Stepanenko, S. A. Yamashkin, A. I. Kot’kin, M. A. Yurovskaya, Moscow Univ. Chem. Bull., 2019, 74, 236.
  7. I. S. Stepanenko, S. A. Yamashkin, M. A. Yurovskaya, Moscow Univ. Chem. Bull., 2020, 75, 382.
  8. A. A. Maseikina, I. S. Stepanenko, S. A. Yamashkin, E. D. Slastnikov, Infektsiya i immunitet [Russ. J. Infect. Immunity], 2021, 11, 663; DOI: https://doi.org/10.15789/2220-7619-TEO-1451 (in Russian).
  9. Pat. RU 2721833; Byul. Izobret. [Inventor Bull.], 2020, No. 15 (in Russian).
  10. S. A. Yamashkin, G. A. Romanova, I. S. Romanova, M. A. Yurovskaya, Chem. Heterocycl. Compd., 2003, 39, 1188.
  11. P. B. Terent’ev, F. P. Stankyavichus, Mass-spectrometriya biologicheski activnykh azotistykh osnovaniy [Mass Spectrometry of Biologically Active Nitrogenous Bases], Mokslas, Vilnius, 1987, p. 280 (in Russian).
  12. A. T. Lebedev, Mass-spectrometriya v organicheskoy khimii [Mass Spectrometry in Organic Chemistry], BINOM. Laboratoriya Znaniy, Moscow, 2010, p. 229 (in Russian).
  13. E. S. Il’inykh, Mass-spectrometriya v organicheskoy khimii [Mass Spectrometry in Organic Chemistry], Publ. Centre of SUSU, Chelyabinsk, 2016, p. 63 (in Russian).
  14. P. B. Terent’ev, Mass-spectrometriya v organicheskoy khimii [Mass Spectrometry in Organic Chemistry], Vysshaya Shkola, Moscow, 1979, p. 83 (in Russian).
  15. D. A. Filimonov, D. S. Druzhilovsky, A. A. Lagunin, T. A. Gloriozova, A. V. Rudik, A. V. Dmitriev, P. V. Pogodin, V. V. Poroikov, Biomed. Chemistry: Research and Methods, 2018, 1, e00004; DOI: https://doi.org/10.18097/BMCRM00004. (in Russian)
  16. D. A. Filimonov, A. A. Lagunin, T. A. Gloriozova, A. V. Rudik, D. S. Druzhilovskiy, P. V. Pogodin, V. V. Poroikov, Chem. Heterocycl. Compd., 2014, 50, 444; DOI: https://doi.org/10.1007/s10593-014-1496-1.
  17. V. V. Poroikov, D. A. Filimonov, T. A. Gloriozova, A. A. Lagunin, D. S. Druzhilovskiy, A. V. Rudik, L. A. Stolbov, A. V. Dmitriev, O. A. Tarasova, S. M. Ivanov, P. V. Pogodin, Russ. Chem. Bull., 2019, 68, 2143; DOI: https://doi.org/10.1007/s11172-019-2683-0.
  18. A. Varnek, in Chemoinformatics Approaches to Virtual Screening, RSC Publ., Cambridge, 2008, 335 pp.
  19. G. Bourgeau, H. Lapointe, P. Péloquin, D. Mayrand, Infect. Immun., 1992, 60, 3186; DOI: https://doi.org/10.1128/iai.60.8.3186-3192.1992.
  20. J. Yang, H.-L. Zhao, Li-Y. Ran, Ch.-Y. Li, X.-Y. Zhang, H.-N. Su, M. Shi, B.-Ch. Zhou, X.-L. Chen, Yu-Zh. Zhang, Sci. Rep., 2015, 5, Art. No. 9936; DOI: https://doi.org/10.1038/srep09936.
  21. J. van Heijenoort, Nat. Prod. Rep., 2001, 18, 503; DOI: https://doi.org/10.1039/a804532a.
  22. L. Glaser, J. Biol. Chem., 1959, 234, 2801; DOI: https://doi.org/10.1016/S0021-9258(18)69673-5.
  23. J. Sun, Z. Deng, A. Yan, Biochem. Biophys. Res. Commun., 2014, 453, 254; DOI: https://doi.org/10.1016/j.bbrc.2014.05.090.
  24. V. Hritonenko, C. Stathopoulos, Mol. Membr. Biol., 2007, 24, 395; DOI: https://doi.org/10.1080/09687680701443822.
  25. B. C. Yowler, R. D. Kensinger, C. L. Schengrund, J. Biol. Chem., 2002, 277, 32815; DOI: https://doi.org/10.1074/jbc.M205258200.
  26. S. E. St. John, S. Tomar, S. R. Stauffer, A. D. Mesecar, Bioorg. Med. Chem., 2015, 23, 6036; DOI: https://doi.org/10.1016/j.bmc.2015.06.039.
  27. E. N. Padeiskaya, Infektsii i antimicrob. terapiya [Infections and Antimicrobial Therapy], 2001, 3, 105 (in Russian).
  28. E. A. Alyamkina, N. V. Zhukova, G. A. Soldovnikova, S. A. Yamashkin, Sintez indol’nykh sistem [Synthesis of Indole Systems], Mordovian State Pedagogical University, Saransk, 2010, 31 pp. (in Russian).
  29. Klin. microbiologiya i antimicrob. khimoterapiya [Clinical Microbiology and Antimicrobial Chemotherapy], 2004, 6, 306 (in Russian).
  30. Rukovodstvo po provedeniyu dokliniycheskikh issledovaniy lekarstvennykh sredstv [Guidelines for Conducting Preclinical Studies of Medicinal Products], Ed. A. N. Mironov, Grif i K, Moscow, 2012, 944 pp. (in Russian).
  31. Opredelenie chuvstvitel’nosti microorganismov k antimikrobnym preparatam: klinicheskie recomendatsii [Determination of the Sensitivity of Microorganisms to Antimicrobial Drugs: Clinical Guidelines]; https://www.antibiotic.ru/files/321/clrec-dsma2018.pdf.